Výsledky vyhledávání

The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine

Autor: Xie, G, Nie, T, Mackenzie, GG, Sun, Y, Huang, L, Ouyang, N, Alston, N, Zhu, C, Murray, OT, Constantinides, PP, Kopelovich, L, Rigas, B

Phospho-sulindac (PS; OXT-328) prevents colon cancer in mice, especially when combined with difluoromethylornithine (DFMO). Here, we explored its metabolism and pharmacokinetics.PS metabolism was studied in cultured cells, liver microsomes and cytoso

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0ab0a604aac7f469874a2985db54cdde
https://europepmc.org/articles/PMC3413853/

Zobrazit plný text záznamu

The history of the growth and decline of the small prairie agricultural service community Poplar Point, Manitoba as an example

Autor: Murray, Ottilie

Externí odkaz: http://hdl.handle.net/1993/9813

Zobrazit plný text záznamu

Dissertation/ Thesis

Cellulose and Its Derivatives.

Autor: Murray, Otis Willard

Publikováno v: Dissertations, Theses, and Masters Projects.

Externí odkaz: https://scholarworks.wm.edu/etd/1593092172
https://scholarworks.wm.edu/cgi/viewcontent.cgi?article=7043&context=etd

Zobrazit plný text záznamu

Akademický článek

Phospho-sulindac inhibits pancreatic cancer growth: NFATc1 as a drug resistance candidate.

Autor: Murray OT; Division of Cancer Prevention, Department of Medicine, Stony Brook University, Stony Brook, NY 11794-8173, USA., Wong CC; Division of Cancer Prevention, Department of Medicine, Stony Brook University, Stony Brook, NY 11794-8173, USA., Vrankova K; Division of Cancer Prevention, Department of Medicine, Stony Brook University, Stony Brook, NY 11794-8173, USA., Rigas B; Division of Cancer Prevention, Department of Medicine, Stony Brook University, Stony Brook, NY 11794-8173, USA.

Publikováno v: International journal of oncology [Int J Oncol] 2014 Feb; Vol. 44 (2), pp. 521-9. Date of Electronic Publication: 2013 Nov 27.

Zobrazit plný text záznamu

Akademický článek

The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine.

Autor: Xie G; Department of Medicine, Stony Brook University, Stony Brook, NY, USA., Nie T, Mackenzie GG, Sun Y, Huang L, Ouyang N, Alston N, Zhu C, Murray OT, Constantinides PP, Kopelovich L, Rigas B

Publikováno v: British journal of pharmacology [Br J Pharmacol] 2012 Apr; Vol. 165 (7), pp. 2152-66.

Zobrazit plný text záznamu

Akademický článek

Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect.

Autor: Zhao W; Department of Medicine, Division of Cancer Prevention, Stony Brook University, Stony Brook, NY 11794-5200, USA., Mackenzie GG, Murray OT, Zhang Z, Rigas B

Publikováno v: Carcinogenesis [Carcinogenesis] 2009 Mar; Vol. 30 (3), pp. 512-9. Date of Electronic Publication: 2009 Jan 09.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání